$48.28
Today
as of Sep 4, 16:46 ET
Last 30 days
Recent Press Releases & News
Axogen, Inc. to Participate in the 24th Annual Morgan Stanley Global Healthcare Conference
Truist Securities Initiates Axogen at Buy With $60 Price Target
Axogen Insider Sold Shares Worth $646,592, According to a Recent SEC Filing
Overview
52-week range
$15
$53
88% of range
Avg surprise (last 2)
+68.1%
Avg reaction (last 1)
-23.2%
0% positive
Latest IV / EM
76%
EM ±11.9% · $50 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.03 | — | — | — | — | financials |
| Tue Mar 31, 2026 | Mar 2026 | $-0.38 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $0.01 | — | — | — | — | financials |
| Tue Aug 5, 2025 | Jun/2025 | $0.01 | $-0.04 | +125.0% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $-0.08 | $-0.09 | +11.1% | — | -23.2% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.04 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.04 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.15 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.10 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.16 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.17 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $70M | $61M | — | $60M | $57M | $49M | — | $49M |
| Cost of revenue | $19M | $15M | — | $14M | $15M | $14M | — | $12M |
| Gross profit | $51M | $46M | — | $46M | $42M | $35M | — | $36M |
| Operating income | $-2M | $-3M | — | $2M | $2M | $-2M | — | $-316,000 |
| Net income | $-2M | $-20M | — | $708,000 | $579,000 | $-4M | — | $-2M |
| EPS (diluted) | $-0.03 | $-0.38 | — | $0.01 | $0.01 | $-0.08 | — | $-0.04 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $95M | $83M | $36M | $24M | $20M | $18M | $28M | $19M |
| Inventory | $47M | $46M | $42M | $41M | $37M | $36M | $33M | $29M |
| Total current assets | $200M | $185M | $120M | $114M | $103M | $93M | $99M | $86M |
| Total assets | $305M | $289M | $222M | $216M | $205M | $196M | $204M | $192M |
| Long-term debt | $0 | $0 | $48M | $48M | $48M | $48M | $47M | $47M |
| Total liabilities | $49M | $45M | $93M | $96M | $93M | $91M | $100M | $93M |
| Total equity | $256M | $245M | $129M | $121M | $112M | $105M | $104M | $99M |